Comparison of the efficacy of treatment of retinal macular inflammation due to diabetes with ozurdex or with ozurdex plus laser treatment in the area.

Registry ID

EUCTR2016-003870-41

Source registry

EUCTR

Status

Restarted

Phase

PHASE4

Sponsor

Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias

Start date

2017-02-07

Last update

2026-08-16

Conditions

• Diabetic macular edema

Summary

To compare the results of treatment of diabetic macular edema with Ozurdex® (sustained release dexamethasone implant) versus Ozurdex® plus selective photocoagulation of the areas of non-perfusion. We will compare both measured functional response and better corrected visual acuity, such as the anatomical response measured by optical coherence tomography (OCT) and the side effects of the treatment.

Locations

• , , Spain

View on source registry